Year |
Citation |
Score |
2018 |
Koltun ES, Aay N, Buckl A, Jogalekar AS, Kiss G, Marquez A, Mellem KT, Mordec K, Saldajeno-Concar M, Semko CM, Tibrewal N, Tzitzilonis C, Won W, Smith JA, Wilson SE, et al. Abstract 4878: RMC-4550, an allosteric inhibitor of SHP2: Synthesis, structure, and anti-tumor activity Cancer Research. 78: 4878-4878. DOI: 10.1158/1538-7445.Am2018-4878 |
0.396 |
|
2018 |
Wildes D, Aay N, Buckl A, Hsieh D, Jogalekar AS, Kiss G, Koltun ES, Marquez A, Mellem KT, Romero J, Saldajeno-Concar M, Schulze CJ, Semko CM, Won W, Nichols RJ, et al. Abstract 4877: Allosteric inhibition of SHP2 variants containing cancer-associated activating mutations Cancer Research. 78: 4877-4877. DOI: 10.1158/1538-7445.Am2018-4877 |
0.342 |
|
2011 |
Jogalekar AS, Damodaran K, Kriel FH, Jung WH, Alcaraz AA, Zhong S, Curran DP, Snyder JP. Dictyostatin flexibility bridges conformations in solution and in the β-tubulin taxane binding site. Journal of the American Chemical Society. 133: 2427-36. PMID 21299225 DOI: 10.1021/Ja1023817 |
0.445 |
|
2010 |
Heathcote DA, Patel H, Kroll SH, Hazel P, Periyasamy M, Alikian M, Kanneganti SK, Jogalekar AS, Scheiper B, Barbazanges M, Blum A, Brackow J, Siwicka A, Pace RD, Fuchter MJ, et al. A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administration. Journal of Medicinal Chemistry. 53: 8508-22. PMID 21080703 DOI: 10.1021/Jm100732T |
0.459 |
|
2010 |
Jogalekar AS. Conformations of stevastelin C3 analogs: Computational deconvolution of NMR data reveals conformational heterogeneity and novel motifs Biopolymers. 93: 968-976. PMID 20564058 DOI: 10.1002/Bip.21504 |
0.37 |
|
2010 |
Jogalekar AS, Kriel FH, Shi Q, Cornett B, Cicero D, Snyder JP. The discodermolide hairpin structure flows from conformationally stable modular motifs Journal of Medicinal Chemistry. 53: 155-165. PMID 19894728 DOI: 10.1021/Jm9015284 |
0.386 |
|
2009 |
Ali S, Heathcote DA, Kroll SH, Jogalekar AS, Scheiper B, Patel H, Brackow J, Siwicka A, Fuchter MJ, Periyasamy M, Tolhurst RS, Kanneganti SK, Snyder JP, Liotta DC, Aboagye EO, et al. The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity. Cancer Research. 69: 6208-15. PMID 19638587 DOI: 10.1158/0008-5472.Can-09-0301 |
0.456 |
|
Show low-probability matches. |